Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials

Rheumatology (Oxford). 2020 Oct 1;59(10):e74-e75. doi: 10.1093/rheumatology/keaa286.

Authors

Kieran E Murray^{1

2}, Matthew A Turk^{1

2}, Douglas J Veale^{1

2}

Affiliations

¹ Department of Rheumatology, Saint Vincent's University Hospital.
² EULAR Centre For Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland.

PMID: 32705141
DOI: 10.1093/rheumatology/keaa286

No abstract available

Publication types

Comment

MeSH terms

Antirheumatic Agents* / adverse effects
Humans
Methotrexate / adverse effects
Rheumatic Diseases* / complications
Rheumatic Diseases* / drug therapy

Substances

Antirheumatic Agents
Methotrexate